Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Expression profiling of hypoxic HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells: time course

OTHER RELATED OMICS DATASETS IN: GSE18505

PROVIDER: PRJNA123717 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Expression profiling of hypoxic HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells: time course

Project description:Analysis of expression changes of cultured HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells subjected to hypoxia (0.5% O2) for 0, 4, 8, 12 hours . Results provide insight to cell type-specific response to hypoxia. HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells were collected under normoxic conditions (~19% O2, 0 hours) and after 4, 8 and 12 hours of hypoxia treatment (0.5% O2). For each cell line, three replicates of total RNA at each time point were prepared using Trizol and submitted to the DFCI Microarray Core for labeling, hybridization to Affymetrix HG-U133Plus2 oligonucleotide arrays and image scanning.

2010-06-21 | E-GEOD-18494 | biostudies-arrayexpress

Expression profiling of hypoxic HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells: time course

2009-10-09 | GSE18494 | GEO

Project description:HepG2 hepatoma and U87 glioma cells: transcriptomic and genomic analyses

| PRJNA120255 | ENA

Splicing and gene expression changes in cell lines treated with splicing switching oligonucleotide targeting TRA2B

Project description:RNA-sequencing data from MDA-MB231 breast cancer cells, U87MG glioblastoma cells, and mouse breast cancer PDX models treated with antisense oligonucleotides targeting exon 2 of TRA2B. Additionally, RNA-sequencing data from MDA-MB231 breast cancer cells and U87MG glioblastoma cells treated with siRNAs targeting TRA2B. RNA-sequencing data from MDA-MB231 breast cancer cells nad U87MG glioblastoma cells treated with antisense oligonucleotides targeting exon 2 of TRA2B.

2024-12-20 | GSE231555 | GEO

E-GEOD-48786

Project description:Expression data from endothelial cells sorted from breast cancer cells MDA-MB231 as compared with normal endothelial cells

2025-01-24 | E-GEOD-48786 | ExpressionAtlas

Genome-wide HIF-1, RNA polII, and H3K4me3 binding sites in U87 and HepG2 cells

Project description:Hypoxia-Inducible Factor 1 (HIF-1) plays a key role in cellular adaptation to hypoxia. To better understand the determinants of HIF-1 binding and transactivation, we used ChIP-chip and gene expression profiling to define the relationship between the epigenetic landscape, sites of HIF-1 binding, and genes transactivated by hypoxia in two cell lines, HepG2 hepatoma cell line and U87 glioma cell line.

2009-10-09 | GSE18499 | GEO

The time-dependent effects of ONC201 on transcriptome in MDA-MB-231 cells

Project description:Goal of this study was to investigate the time-dependent impact of ONC201 on gene expression changes in MDA-MB231, a triple negative breast cancer cell line

2022-08-30 | GSE212369 | GEO

Untargeted metabolomics of breast cell lines in the presence or the absence of CtBP inhibitors

Project description:Experiments to test the effect of CtBP2 inhibition on metabolism of breast cell lines. In particular, experiment 1 involves comparison between a normal breast cell line (MCF102A) and a triple-negative breast cancer cell line (MDA-MB231). Experiment 2 is a study between MDA-MB231 silenced for CtBP2 by stable RNA interference (shCtBP2 cells) compared to scramble (shCTRL cells). Experiment 3 is a comparison between a normal breast cell line (MCF102A) and a triple-negative breast cancer cell line (MDA-MB231)in the presence of the absence of small-molecule CtBP inhibitors: HIPP (400 μM) or P4 (300 μM)for 48 hours.

2021-08-31 | ST001941 | MetabolomicsWorkbench

E-GEOD-34925

Project description:Expression data from knockdown of G9a in MDA-MB231 cells

2025-01-24 | E-GEOD-34925 | ExpressionAtlas

Genome-wide maps of chromatin modifications in a breast cancer cell line

Project description:We report the H3K27ac status in MDA-MB231 breast cancer cells after knockdown of CDK19 and CDK8.

2019-01-01 | GSE103887 | GEO